Table 1 Clinical and laboratory characteristics of the SLE patients studied

1

HCQ 200 mg/d

3.8

16.3

23

1.3

<5

54

13

0.24

3

2

Pred 5 mg/d, HCQ 200 mg/d

2.04

8.6

352

1.04

18

80

15

NA

1

3

Pred 12.5 mg/d, MMF 3 mg/d

10.55

9.2

281

0.45

34

72

24

6.57

6

4

HCQ 300 mg/d

2.38

12.1

149

0.64

127

29

7.1

<0.06

16

5

Pre 15 mg/d, HCQ 200 mg/d, Aza 100 mg/d

0.8

8.9

67

.3

19

94

19

0.18

6

6

Pred 20 mg/d, HCQ 400 mg/d

1.93

11.5

131

0.49

54

36

2.9

NA

15

7

Pred 7.5 mg/d, Aza 50 mg/d, MMF 1 mg/d

2.3

9.0

70

0.2

150

27

9.9

0.26

15

8

Pred 20 mg/d

4.9

10.4

207

1.4

9

67

13

NA

6

9

HCQ 200 mg/d

2.06

7.4

94

0.82

85

31

5.3

3.63

13

10

Pred 12.5 mg/d MMF 3 g/d

6.0

12.0

74

0.6

45

58

27

0.11

15

11

Pred 50 mg/d

3.54

9.4

47

0.9

29

101

34

NA

2

12

Pred 15 mg/d, HCQ 200 mg/d, Aza 100 mg/d

5.21

11.6

31

0.25

12

109

23

NA

1

13

HCQ 300 mg/d

4.1

9.5

92

1.2

>450

26

3.7

2.4

14